The cognitive effects of conventional and atypical antipsychotics in schizophrenia

被引：0
|
作者：
Haraszti, L [1 ]
Somogyi, D [1 ]
机构：
[1] Flor Ferenc Cty Hosp, Kistarcsa, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] On conventional and atypical antipsychotics induced hyperprolactinaemia
    Hermle, L.
    Boensh, A.
    Ruchsow, M.
    NERVENHEILKUNDE, 2007, 26 (05) : 417 - 419
  • [42] Conventional and atypical antipsychotics: Neither safer
    Ebell, M
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (08) : 1446 - 1446
  • [43] Conventional and Atypical Antipsychotics in the ElderlyA Review
    Pietro Gareri
    Pasquale De Fazio
    Mariagrazia Stilo
    Guido Ferreri
    Giovambattista De Sarro
    Clinical Drug Investigation, 2003, 23 : 287 - 322
  • [44] Atypical antipsychotics in the treatment of schizophrenia - Reply
    Geddes, J
    Harrison, P
    Freemantle, N
    Bebbington, P
    BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 927 - 928
  • [45] Schizophrenia, weight gain and atypical antipsychotics
    Brown, S
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 191 - 192
  • [46] Schizophrenia therapy: beyond atypical antipsychotics
    Eric M. Snyder
    Melanie R. Murphy
    Nature Reviews Drug Discovery, 2008, 7 : 471 - 472
  • [47] Selection of atypical antipsychotics for the management of schizophrenia
    Sprague, DA
    Loewen, PS
    Raymond, CB
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 313 - 319
  • [48] Schizophrenia therapy: beyond atypical antipsychotics
    Snyder, Eric M.
    Murphy, Melanie R.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 471 - 472
  • [49] Dose Response and Atypical Antipsychotics in Schizophrenia
    Bruce J. Kinon
    Jonna Ahl
    Virginia L. Stauffer
    Angela L. Hill
    Peter F. Buckley
    CNS Drugs, 2004, 18 : 597 - 616
  • [50] The use of atypical antipsychotics in the management of schizophrenia
    Campbell, M
    Young, PI
    Bateman, DN
    Smith, JM
    Thomas, SHL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 13 - 22
12345